Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains. 2012

Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
Laboratory of Virology and Vaccinology, Division of Biomedical Research, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan.

Dextran sulfate (DS), a negatively charged, sulfated polysaccharide, suppresses the replication of an influenza A virus strain, and this suppression is associated with inhibition of the hemagglutinin (HA)-dependent fusion activity. However, it remains unknown whether the replication of all or just some influenza A virus strains is suppressed by DS, or whether HA is the only target for the replication suppression. In the present study, we found that DS inhibited the replication of some, but not all influenza A virus strains. The suppression in the DS-sensitive strains was dose-dependent and neutralized by diethylaminoethyl-dextran (DD), which has a positive charge. The suppression by DS was observed not only at the initial stage of viral infection, which includes viral attachment and entry, but also at the late stage, which includes virus assembly and release from infected cells. Electron microscopy revealed that the DS induced viral aggregation at the cell surface. The neuraminidase (NA) activity of the strains whose viral replication was inhibited at the late stage was also more suppressed by DS than that of the strains whose replication was not inhibited, and this inhibition of NA activity was also neutralized by adding positively charged DD. Furthermore, we found that replacing the NA gene of a strain in which viral replication was inhibited by DS at the late stage with the NA gene from a strain in which viral replication was not inhibited, eliminated the DS-dependent suppression. These results suggest that the influenza virus NA contributes to the DS-suppressible virus release from infected cells at the late stage, and the suppression may involve the inhibition of NA activity by DS's negative charge.

UI MeSH Term Description Entries
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D003637 DEAE-Dextran Used as a support for ion-exchange chromatography. DEAE Sephadex,Diethylaminoethyldextran,Pulsar,DEAE Dextran,Sephadex, DEAE
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
July 2005, The Journal of infectious diseases,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
July 1990, Antiviral research,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
January 2012, PloS one,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
May 1970, FEBS letters,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
January 1995, Virus genes,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
June 2013, The Journal of biological chemistry,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
November 2009, Biochemical and biophysical research communications,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
February 2019, The Journal of experimental medicine,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
November 2010, The Journal of general virology,
Hiroshi Yamada, and Eiko Moriishi, and Ahmad M Haredy, and Nobuyuki Takenaka, and Yasuko Mori, and Koichi Yamanishi, and Shigefumi Okamoto
November 2014, The Journal of general virology,
Copied contents to your clipboard!